Fluorofenidone is a pyridone derivative acting as a TGF-β1 and p38γ inhibitor, primarily utilized in preclinical research to investigate therapeutic potential against fibrotic diseases of the liver, kidneys,… Read more
Fluorofenidone is a pyridone derivative acting as a TGF-β1 and p38γ inhibitor, primarily utilized in preclinical research to investigate therapeutic potential against fibrotic diseases of the liver, kidneys, and lungs. Analytical laboratories require high-quality Fluorofenidone reference standards to facilitate rigorous quality control and method validation for this compound. This category includes the parent drug alongside its specific degradation products, such as Fluorofenidone Impurity 1 and Impurity 2, which are essential for comprehensive impurity profiling. Additionally, stable isotope labelled compounds, including deuterated versions of the parent molecule and its impurities, are available to serve as internal standards. These labelled analogues are critical for accurate quantification in complex biological matrices when using mass spectrometry assays, ensuring precise measurement and reliable data throughout the drug development process.